of mitochondrial OCR. Conclusion: TGFβ-induced rearrangements of actin cytoskeleton are controlled by Smad2/3 signaling pathways and coupled with the activation of mitochondrial ATP synthesis as bioenergetic adaptation to ATP consumption by ATP-and GTP-dependent motor proteins, myosin II and dynamin.
nestrated endothelial layer in the glomerulus. Podocyte cellular morphology is tightly connected to their function and structural rearrangements leading to foot processes effacement correlate with proteinuria [5] . Our group demonstrated a prominent role for TGFβ signaling in podocyte apoptosis and depletion in vitro and in vivo [2] . The pro-apoptotic activities are consistent with recent reports that demonstrate increase of TGFβ ligand and/or receptors in podocytes both in experimental models and in human diseases with glomerulosclerosis [6, 7] .
There is increasing evidence (in vitro and in vivo) suggesting that mitochondrial dysfunction is involved in renal disease onset and progression [8, 9] .
Here we report a functional interaction between TGFβ/Smad signaling and mitochondrial metabolism in podocyte cytoskeleton dynamics. We demonstrate that mitochondrial activity increases as an adaptive metabolic response to actin cytoskeleton reorganization induced by TGFβ in podocytes through Smad2/3 pathway signaling. These findings show for the first time a link between cellular imbalances of cytokine signaling, cytoskeleton dynamics, and mitochondrial metabolism, providing a rationale to explore further how these pathways contribute to glomerular cell injury in renal disease.
Materials and Methods
Cell Culture and Inhibitors WT [10] and Smad2/3 KO (DKO) [11] conditionally immortalized mouse podocytes were maintained in RMPI containing antibiotics, 10% fetal bovine serum and 5.5 m M glucose and allowed to differentiate at 37 ° C 5% CO 2 without IFNγ for 5-14 days before experiments. Briefly, DKO cells were obtained by Smad3 KO/ Smad2 floxed podocyte cell line by Cre-mediated recombination by infecting podocytes with Ad5 CMV Cre [11] .
TGFβ: 5 ng/ml. TGFβ receptor I kinase inhibitor LY364947 (Cayman Chemical): 3 μ M with 15 min preincubation. Dynamin inhibitor dynasore (Ascent Scientific, Princeton, N.J., USA): 10 μ M with 30 min pretreatment. Blebbistatin (Sigma-Aldrich, St. Louis, Mo., USA), inhibitor of non-muscle myosin II: 5 μ M with 30 min pretreatment. Acetovanillone/apocynin (Sigma-Aldrich, St. Louis, Mo., USA): 50 μ M with 30 min pretreatment to inhibit NADPH oxidase.
Oxygen Consumption Rate
Podocytes were plated in collagen I coated XF24-well microplates (Seahorse Bioscience, North Billerica, Mass., USA). Oxygen consumption rate (OCR) was analyzed with the Seahorse Bioscience XF24 Extracellular Flux Analyzer over time by collecting three measurements of baseline rates and two measurements after either 1 μ M oligomycin (sigma) injection, 1 μ M FCCP (carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone) (Sigma-Aldrich, St. Louis, Mo., USA) injection, or 0.5 μ M rotenone (Sigma-Aldrich, St. Louis, Mo., USA) injection. Results are shown as baseline respiration because they are representative of the overall behavior of the samples. 
ATP Content

Reactive Oxygen Species Detection and Apoptosis
Reactive oxygen species (ROS) were quantified using a BD FACSCanto (BD Biosciences, San Jose, Calif., USA), and data were processed using FACS Diva software (BD, San Jose, Calif., USA). A combination of 5 μ M of CM-H 2 DCFDA (Invitrogen, Carlsbad, Calif., USA) and 5 μ M MitoSOX (Invitrogen, Carlsbad, Calif., USA) were used for general ROS and mitochondrial-specific superoxide detection, respectively, according to manufacturer instructions. Apoptosis was measured by flow cytometry (Annexin/ PI, BD Biosciences, San Jose, Calif., USA).
Statistical Analysis
Data were analyzed with analysis of variance (significance set at 5%) followed by Bonferroni test. Results are presented as mean ± SEM of at least 3 independent experiments.
Results
TGFβ/Smad Stimulation Induces Compensatory Mitochondrial Respiration and ATP Synthesis in Podocytes
Mitochondrial metabolic activity was assessed by measuring baseline and ATP synthesis-linked OCR in WT and Smad2/3 double KO podocytes after stimulation with TGFβ for 6, 24, or 48 h ( fig. 1 a and b) . TGFβ treatment induced a significant increase of basal mitochondrial OCR starting at 24 h in WT podocytes ( fig. 1 a) . In contrast, TGFβ had no statistical significant effect on basal OCR in WT cells pretreated with TGFβ receptor type 1 kinase inhibitor (LY), or in Smad2/3-deficient DKO podocytes ( fig. 1 a) . The increase of oxygen consumption in WT podocytes was associated with increased ATP synthesis and not caused by mitochondrial uncoupling, as demonstrated by the increased oligomycin-sensitive respiration ( fig. 1 b) . TGFβ did not affect citrate synthase activity ( fig. 1 d) , indicating that mitochondrial biogenesis and mitochondrial mass were not altered. Because ATP content in WT podocytes was not altered up to 48 h by TGFβ ( fig. 1 c) , we concluded that the increase in mitochondrial oxygen consumption and ATP synthesis were required to maintain a steady-state ATP level during increased cellular ATP consumption by podocytes stimulated with TGFβ.
Adaptive changes in mitochondrial metabolism are often associated with alteration of mitochondrial morphology. TGFβ did not induce significant changes in mitochondrial network interconnectivity as shown in online supplemental figure 1A (for all online suppl. material, see www.karger.com/doi/10.1159/000442051).
NADPH Oxidase-Dependent ROS Generation Is Induced by TGFβ through Smad-Dependent Pathways
TGFβ stimulates ROS production by NADPH oxidases in multiple cell types, including podocyte [12] . We observed a nonsignificant increase of cytosolic ROS in WT, but not in DKO podocytes after 24 and 48 h of TGFβ stimulation ( fig. 2 a) . Pretreatment of WT podocytes with apocynin, an NADPH oxidase inhibitor, reverted the nonsignificant trend toward TGFβ-induced ROS increase ( fig. 2 b) . Apocynin did not affect TGFβ-induced stimulation of mitochondrial OCR in WT podocytes (OCR % control: 100 ± 2.60, Apo 24 h: 98 ± 2.60, Apo TGFβ 24 h: 140 ± 1.16). We next assessed the contribution of mitochondrial ROS using two methods: MitoSOX labeling to detect mitochondrial-specific superoxide production and 8oxoG staining to detect accumulation of secondary products of oxidation in the DNA. Consistently with previously published data [13] , TGFβ did not stimulate mitochondrial superoxide production ( fig. 2 c) , in WT or DKO podocytes. Confirming the absence of mitochondrial-derived ROS overproduction, WT podocytes treaded with TGFβ for 48 h and costained with anti-8oxoG and anti-TFAM, a mitochondrial transcription factor, did not show any accumulation of oxidized DNA in mitochondria ( fig. 2 d) . Hydrogen peroxide (H 2 O 2 ) treatment was used as positive control, inducing an expected 8oxoG positive staining in the nuclei ( fig. 2 d) .
As shown in online supplemental figure 1B, TGFβ treatment did not induce a significant increase in apoptosis in WT podocytes. In fact, podocyte viability upon treatment with TGFβ was highly dependent on serum concentration, with TGFβ having an effect at 1% serum or less ( fig. 2 e) . Figure 2 f demonstrates that TGFβ treatment effectively induced Smad2/3 nuclear accumulation in WT podocytes. 
TGFβ-Induced Increased Mitochondrial OCR Is Associated with Energy-Dependent Actin Cytoskeletal Rearrangements
Energy-dependent actin cytoskeleton rearrangements are a well-known consequence of TGFβ signaling in podocytes [14] . We hypothesized that energy dependentactin polymerization induced by TGFβ caused the adaptive increase of mitochondrial OCR in podocytes. WT or DKO podocytes were stained with FITC-conjugated Phalloidin to visualize time-dependent changes in actin organization following treatment with TGFβ. As shown in figure 3 a, a strong increase in F-actin staining -quantified in the bar graph -was detectable in WT, but not in DKO cells treated with TGFβ.
Both myosin II and dynamin are ATP-or GTP-dependent motor proteins respectively involved in cytoskeleton dynamics and relevant for the maintenance of podocyte and kidney function [15] [16] [17] [18] . The TGFβ-induced F-actin increase observed in WT podocytes was prevented by pretreatment with both blebbistatin and dynasore ( fig. 3 b and column graph), demonstrating that energy-dependent myosin and dynamin mediate TGFβ-induced actin reorganization in podocytes.
To examine whether non-muscle myosin or dynaminmediated F-actin formation was associated with upregulation of mitochondrial activity, we tested the effects of both inhibitors on mitochondrial OCR of TGFβ-treated WT podocytes. Treatment with both dynamin and myosin inhibitor prevented the TGFβ-induced increase of mitochondrial OCR ( fig. 3 c) .
Discussion
Our work demonstrates that TGFβ/Smad signaling in podocytes induces non-muscle myosin II and dynamindependent actin cytoskeletal rearrangement, an energyconsuming response that is compensated by adaptive increase in mitochondrial metabolism in the absence of oxidative mitochondrial damage. Stimulation of NADPH oxidase was demonstrated by increased cytoplasmic ROS generation, while no apoptosis was detected.
Stimulation of mitochondrial activity in podocytes treated with TGFβ or high glucose was recently described pointing out the flexibility of energy metabolism in podocytes [19, 20] . With an approach based on the use of different podocyte cell lines, we were able to demonstrate that mitochondrial activity modulation in response to TGFβ is specifically dependent on Smad2/3 signaling and that most likely is a consequence of increased ATP turnover. Increased OCR in absence of mitochondrial uncoupling suggests in fact that TGFβ-stimulated podocytes were metabolically challenged to produce more energy. We did not find evidence pointing toward increased mitochondrial biogenesis and therefore concluded that mitochondrial function was in this context regulated by different mechanisms.
The absence of mitochondrial ROS production by the respiratory chain corroborates the observation that mitochondrial respiration is efficiently coupled to ATP synthesis and is consistent with our previous observations, where in vivo activation of TGFβ receptor I signaling in podocytes did not induce mitochondrial damage or ROS in podocytes [13] .
Podocyte physiology and morphology are deeply connected within a complex 3-dimensional structure defining different intracellular microenvironments. Slit diaphragm proteins are precisely localized to create connections with adjacent cells and contribute to the glomerular filtration barrier. Actin is a central component of cell structure and in podocytes its relevance in cell function other than architecture is demonstrated by its capacity of interaction with many critical components of the slit diaphragm [21] . Several proteins associated with actin stabilization have been proposed to be involved in pathogenic mechanisms causing podocyte injury [22] , while actin targeting has been suggested as a new strategy for kidney disease treatment [23] . Actin polymerization involves the activity of ancillary proteins with different affinity levels for its monomeric or polymeric state. Dynamin and myosin, 2 GTP-and ATP-dependent motor proteins, respectively, involved in actin polymerization have emerged as potentially relevant in podocytes biology. Mutations in dynamin and myosinencoding genes have been in fact associated with impaired glomerular function, indicating that these proteins are essential for the development and maintenance of podocytes foot processes [15, 17, 18, 24] . Evidence linking mitochondrial function and dynamics to actin has been found in neuronal cells where mitochondria size and distribution were affected by actin organization [25] . Cofilin -one of the mediators of actin-mitochondria regulation in neurons [25] -has interestingly been proposed as both a diagnostic marker and pharmaceutical target for podocytopathies [26, 27] , adding to the list of analogies between neurons and podocytes. We hypothesized that TGFβ-induced cytoskeleton rearrangements and energy metabolism stimulation in podocytes were connected. Stabilization of actin cytoskeleton by inhibition of dynamin or myosin was in fact associated with normalization of OCR, supporting the hypothesis that mitochondrial metabolism upregulation observed in TGFβ-treated podocytes represents a compensatory response to increased energy consumption associated with non-muscle myosin II and dynamin-mediated actin cytoskeleton rearrangements. Our results present novel insights in TGFβ-Smad signaling and propose a link between mitochondria metabolism and molecular pathways regulating cytoskeleton dynamics, revealing a novel mechanism relevant for foot processes stabilization and energy homeostasis in podocytes.
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